|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Avant Immunotherapeutics Inc., of Needham, Mass., said its partner, GlaxoSmithKline plc, of London, reported that Mexican authorities approved the Rotarix vaccine for marketing in that country for the prevention of gastroenteritis caused by rotavirus infection. Rotarix is an oral, two-dose, live attenuated vaccine developed from a single human strain designed to protect against multiple rotavirus strains and provide early protection before the onset of infection.
o Avigen Inc., of Alameda, Calif., reduced its staff by 39 percent, laying off 38 employees. The restructuring stems from its recent decision to halt patient enrollment in the Coagulin-B trial for ...